Ovarian endometriomas: the role of aspiration (sclerosing) therapy

In: MOJ Gerontology & Geriatrics · 2018 · vol. 3(3) · doi:10.15406/mojgg.2018.03.00123 · W2849454033
article OA: diamond CC0
📄 Open PDF View on OpenAlex View at publisher

Abstract

The article discusses disputable problems of aspiration therapy of ovarian endometriomas. A comparatively high (43.2%) incidence of relapses of endometriomsa within a 12-month follow-up after sclerosing therapy has been noted. At the same time, pregnancy occurred in 37.3% of women during this period, later ending with childbirth in 100% of cases. Aspiration therapy of ovarian endometriomsa presupposes a careful selection of patients for such intervention. Its favourable outcomes in many respects depend on hormone therapy compliance.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK